The effect of reducing heart rate on central aortic blood pressure: a comparative study of ivabradine and atenolol on haemodynamic parameters at rest
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2012
At a glance
- Drugs Atenolol (Primary) ; Ivabradine (Primary)
- Indications Cardiovascular disorders; Hypertension
- Focus Pharmacodynamics
- 14 Sep 2012 Status changed from completed to discontinued as reported by ISRCTN.
- 01 Jul 2009 Status changed from unconfirmed to completed as reported by ISRCTN.
- 01 Dec 2006 New trial record.